It’s a great place to go on holiday, but if that’s all that
comes to mind when you think about Turkey, then you really
are missing the point. Sue Lee of World Courier gives you
the pharmaceutical R&D perspective. As a bridge between
Europe and the Middle East and Asia, Turkey occupies a
unique position, with a population of around 75 million and
a wide ethnic diversity which offers a great opportunity for
data spread within a clinical trial — all while dealing with one
administration, the Turkish Medicines and Medical Devices
Agency (TMMDA).